BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32539777)

  • 1. Photo-responsive degradable hollow mesoporous organosilica nanoplatforms for drug delivery.
    Fan J; Zhang Z; Wang Y; Lin S; Yang S
    J Nanobiotechnology; 2020 Jun; 18(1):91. PubMed ID: 32539777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
    Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
    Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy.
    Yue J; Luo SZ; Lu MM; Shao D; Wang Z; Dong WF
    Chem Biol Drug Des; 2018 Aug; 92(2):1435-1444. PubMed ID: 29671941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabrication of multifunctional triple-responsive platform based on CuS-capped periodic mesoporous organosilica nanoparticles for chemo-photothermal therapy.
    Cheng X; Li D; Lin A; Xu J; Wu L; Gu H; Huang Z; Liu J; Zhang Y; Yin X
    Int J Nanomedicine; 2018; 13():3661-3677. PubMed ID: 29983561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple stimuli-responsive ZnO quantum dots-conjugated hollow mesoporous carbon nanoplatform for NIR-induced dual model antitumor therapy.
    Feng S; Mao Y; Wang X; Zhou M; Lu H; Zhao Q; Wang S
    J Colloid Interface Sci; 2020 Feb; 559():51-64. PubMed ID: 31610305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
    Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
    Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interface-Engineered Paclitaxel-Based Hollow Mesoporous Organosilica Nanoplatforms for Photothermal-Enhanced Chemotherapy of Tumor.
    Qian C; Al-Hamyari B; Tang X; Hou B; Yang S; Zhang G; Lv H; Yang Z; Wang Z; Shi Y
    Mol Pharm; 2021 Dec; 18(12):4531-4542. PubMed ID: 34739255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable Mesoporous Organosilica Nanosheets for Chemotherapy/Mild Thermotherapy of Cancer: Fast Internalization, High Cellular Uptake, and High Drug Loading.
    Chen L; Meng X; Liu M; Lv R; Cai B; Wang Z
    ACS Appl Mater Interfaces; 2020 Jul; 12(27):30234-30246. PubMed ID: 32525649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and Biological Evaluation of Multiple Modification Hollow Mesoporous Silicone Doxorubicin Nanodrug Delivery System.
    Hu M; Zhang W; Chen W; Chen Y; Huang Q; Bao Q; Lin T; Wang L; Zhang S
    AAPS PharmSciTech; 2022 Jun; 23(6):180. PubMed ID: 35761120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable hollow mesoporous organosilica nanotheranostics (HMONs) as a versatile platform for multimodal imaging and phototherapeutic-triggered endolysosomal disruption in ovarian cancer.
    Li P; Lin B; Chen Z; Liu P; Liu J; Li W; Liu P; Guo Z; Chen C
    Drug Deliv; 2022 Dec; 29(1):161-173. PubMed ID: 34967262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemodrug-Gated Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Multimodal Imaging-Guided Low-Temperature Photothermal Therapy/Chemotherapy of Cancer.
    Wu J; Bremner DH; Niu S; Shi M; Wang H; Tang R; Zhu LM
    ACS Appl Mater Interfaces; 2018 Dec; 10(49):42115-42126. PubMed ID: 30462492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.
    Lu N; Tian Y; Tian W; Huang P; Liu Y; Tang Y; Wang C; Wang S; Su Y; Zhang Y; Pan J; Teng Z; Lu G
    ACS Appl Mater Interfaces; 2016 Feb; 8(5):2985-93. PubMed ID: 26767305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H
    Xu Y; Shi W; Li H; Li X; Ma H
    ChemMedChem; 2019 Jun; 14(11):1079-1085. PubMed ID: 30908865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functionalization of mesoporous organosilica nanocarrier for pH/glutathione dual-responsive drug delivery and imaging of cancer therapy process.
    Hu LL; Meng J; Zhang DD; Chen ML; Shu Y; Wang JH
    Talanta; 2018 Jan; 177():203-211. PubMed ID: 29108577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin and doxorubicin high-loaded nanodrug based on biocompatible thioether- and ethane-bridged hollow mesoporous organosilica nanoparticles.
    Zhang J; Weng L; Su X; Lu G; Liu W; Tang Y; Zhang Y; Wen J; Teng Z; Wang L
    J Colloid Interface Sci; 2018 Mar; 513():214-221. PubMed ID: 29153715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hollow mesoporous organosilica nanoparticles: a generic intelligent framework-hybridization approach for biomedicine.
    Chen Y; Meng Q; Wu M; Wang S; Xu P; Chen H; Li Y; Zhang L; Wang L; Shi J
    J Am Chem Soc; 2014 Nov; 136(46):16326-34. PubMed ID: 25343459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable hollow mesoporous organosilica nanotheranostics (HMON) for multi-mode imaging and mild photo-therapeutic-induced mitochondrial damage on gastric cancer.
    Guo W; Chen Z; Chen J; Feng X; Yang Y; Huang H; Liang Y; Shen G; Liang Y; Peng C; Li Y; Li G; Huang W; Zhao B; Hu Y
    J Nanobiotechnology; 2020 Jul; 18(1):99. PubMed ID: 32690085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intercellular adhesion molecule 1 antibody-mediated mesoporous drug delivery system for targeted treatment of triple-negative breast cancer.
    Wang M; Liu W; Zhang Y; Dang M; Zhang Y; Tao J; Chen K; Peng X; Teng Z
    J Colloid Interface Sci; 2019 Mar; 538():630-637. PubMed ID: 30554096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acidity/Reducibility Dual-Responsive Hollow Mesoporous Organosilica Nanoplatforms for Tumor-Specific Self-Assembly and Synergistic Therapy.
    Tang W; Fan W; Wang Z; Zhang W; Zhou S; Liu Y; Yang Z; Shao E; Zhang G; Jacobson O; Shan L; Tian R; Cheng S; Lin L; Dai Y; Shen Z; Niu G; Xie J; Chen X
    ACS Nano; 2018 Dec; 12(12):12269-12283. PubMed ID: 30418749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
    Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
    Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.